DENTSPLY SIRONA’s Potential Growth and Buy Rating Reaffirmed Despite Current EPS Shortfall
Needham analyst David Saxon reiterated a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $25.00.Invest ...
Yahoo Finance5d
DENTSPLY SIRONA Inc. (XRAY)
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor ...
Wall Street Journal2d
Dentsply Sirona Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Wall Street Journal5d
Dentsply Sirona Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
TheUrbanDeveloper2d
Perth Developer Resurrects Mothballed Apartment Project
Sirona Urban has submitted a development application to the City of South Perth for a $120-million mixed-use tower at 31 Labouchere Road, South Perth, reducing the project from its original 38 storeys ...
morningstar.com.au6d
Sirona Biochem Corp
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to ...